Furthermore, one study found that MDK can promote phagocytic activity and lipid metabolism in macrophages, conferring a phenotype that promotes osimertinib resistance in metastatic non-small-cell lung cancer [118]. The gene discussed is MDK; the disease is non-small cell lung carcinoma.